Pages that link to "Q24203736"
Jump to navigation
Jump to search
The following pages link to Stem cell treatment for acute myocardial infarction (Q24203736):
Displaying 50 items.
- Cardiac regeneration and diabetes (Q21195758) (← links)
- Discrepancies in autologous bone marrow stem cell trials and enhancement of ejection fraction (DAMASCENE): weighted regression and meta-analysis (Q22306551) (← links)
- Stem cell treatment for acute myocardial infarction (Q24186920) (← links)
- Transmyocardial laser revascularization versus medical therapy for refractory angina (Q24187921) (← links)
- Stem cell therapy for chronic ischaemic heart disease and congestive heart failure (Q24194988) (← links)
- Young at Heart: Pioneering Approaches to Model Nonischaemic Cardiomyopathy with Induced Pluripotent Stem Cells (Q26750663) (← links)
- Application and Progress of Combined Mesenchymal Stem Cell Transplantation in the Treatment of Ischemic Cardiomyopathy (Q26796004) (← links)
- Autologous Stem Cell Therapy: How Aging and Chronic Diseases Affect Stem and Progenitor Cells (Q26796809) (← links)
- Stem cell imaging: from bench to bedside (Q26861615) (← links)
- Chemokine contribution in stem cell engraftment into the infarcted myocardium (Q26863520) (← links)
- Concise review: therapeutic potential of adipose tissue-derived angiogenic cells (Q26998587) (← links)
- Impact of intracoronary bone marrow cell therapy on left ventricular function in the setting of ST-segment elevation myocardial infarction: a collaborative meta-analysis (Q27001633) (← links)
- Concise review: heart regeneration and the role of cardiac stem cells (Q27021931) (← links)
- Stem cell mechanisms during left ventricular remodeling post-myocardial infarction: Repair and regeneration (Q27026285) (← links)
- Preconditioning via angiotensin type 2 receptor activation improves therapeutic efficacy of bone marrow mononuclear cells for cardiac repair (Q27341905) (← links)
- The winding road to regenerating the human heart (Q28081476) (← links)
- Adult Bone Marrow Cell Therapy for Ischemic Heart Disease: Evidence and Insights From Randomized Controlled Trials (Q28082162) (← links)
- Challenges in identifying the best source of stem cells for cardiac regeneration therapy (Q28083859) (← links)
- Fifteen years of bone marrow mononuclear cell therapy in acute myocardial infarction (Q29994502) (← links)
- Stem cell therapy for chronic ischaemic heart disease and congestive heart failure. (Q30239945) (← links)
- Cell therapy for cardiac repair--lessons from clinical trials. (Q30359782) (← links)
- Diabetes-associated macrovascular complications: cell-based therapy a new tool? (Q30428895) (← links)
- Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data (Q30896351) (← links)
- Stem cell therapies for the treatment of radiation-induced normal tissue side effects (Q33768112) (← links)
- Bone marrow mesenchymal stem cell-derived vascular endothelial growth factor attenuates cardiac apoptosis via regulation of cardiac miRNA-23a and miRNA-92a in a rat model of myocardial infarction (Q33853277) (← links)
- Concise review: diabetes, the bone marrow niche, and impaired vascular regeneration. (Q33975637) (← links)
- New coronary retroinfusion technique in the Rat infarct model: transjugular cardiac vein catheterization (Q34163691) (← links)
- Long-term effects of autologous bone marrow stem cell treatment in acute myocardial infarction: factors that may influence outcomes (Q34288961) (← links)
- Blood vessel repair and regeneration in the ischaemic heart (Q34304413) (← links)
- Stem cell-derived endothelial cells for cardiovascular disease: a therapeutic perspective (Q34306425) (← links)
- Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial (Q34467911) (← links)
- Density gradient centrifugation compromises bone marrow mononuclear cell yield (Q34510325) (← links)
- Bone Marrow Stem Cell Treatment for Ischemic Heart Disease in Patients with No Option of Revascularization: A Systematic Review and Meta-Analysis (Q34804229) (← links)
- Bone marrow characteristics associated with changes in infarct size after STEMI: a biorepository evaluation from the CCTRN TIME trial. (Q34807168) (← links)
- Impact of cell number and microvascular obstruction in patients with bone-marrow derived cell therapy: final results from the randomized, double-blind, placebo controlled intracoronary Stem Cell therapy in patients with Acute Myocardial Infarction ( (Q34879592) (← links)
- Multimodality molecular imaging to monitor transplanted stem cells for the treatment of ischemic heart disease (Q35114568) (← links)
- Cardiac tissue slice transplantation as a model to assess tissue-engineered graft thickness, survival, and function (Q35159811) (← links)
- Magnetic resonance hypointensive signal primarily originates from extracellular iron particles in the long-term tracking of mesenchymal stem cells transplanted in the infarcted myocardium (Q35162387) (← links)
- Cell-based therapy for pediatric traumatic brain injury: not (yet) an update to the traumatic brain injury guidelines. (Q35322191) (← links)
- An emerging consensus on cardiac regeneration (Q35565809) (← links)
- Effect of fatty acids on human bone marrow mesenchymal stem cell energy metabolism and survival (Q35576599) (← links)
- Cyclosporin in cell therapy for cardiac regeneration (Q35619397) (← links)
- Migration towards SDF-1 selects angiogenin-expressing bone marrow monocytes endowed with cardiac reparative activity in patients with previous myocardial infarction (Q35633590) (← links)
- Biomaterial based cardiac tissue engineering and its applications (Q35731251) (← links)
- Randomized trial of combination cytokine and adult autologous bone marrow progenitor cell administration in patients with non-ischaemic dilated cardiomyopathy: the REGENERATE-DCM clinical trial (Q35762717) (← links)
- Advanced Therapy Medicinal Products: How to Bring Cell-Based Medicinal Products Successfully to the Market - Report from the CAT-DGTI-GSCN Workshop at the DGTI Annual Meeting 2014. (Q35789528) (← links)
- Myocardial regeneration strategy using Wharton's jelly mesenchymal stem cells as an off-the-shelf 'unlimited' therapeutic agent: results from the Acute Myocardial Infarction First-in-Man Study. (Q35829154) (← links)
- Nicorandil protects mesenchymal stem cells against hypoxia and serum deprivation-induced apoptosis (Q35849951) (← links)
- Dynamic Support Culture of Murine Skeletal Muscle-Derived Stem Cells Improves Their Cardiogenic Potential In Vitro (Q36016039) (← links)
- Roles of microRNA-34a targeting SIRT1 in mesenchymal stem cells (Q36135052) (← links)